Tegoprazan–Amoxicillin Dual Therapy for Clarithromycin-Resistant <i>Helicobacter pylori</i>: A Feasibility Pilot Study
Tegoprazan (TPZ) has the potential to enhance <i>Helicobacter pylori</i> eradication. This study aimed to investigate the efficacy of TPZ–amoxicillin (TA) dual therapy against clarithromycin-resistant <i>H. pylori</i> strains. All <i>H. pylori</i>-positive patients were diagnosed by real-time polyme...
Gardado en:
| Autor Principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2025-10-01
|
| Series: | Microorganisms |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2076-2607/13/10/2408 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|